$0.775
+0 (+0%)
At Close: Dec 06, 2023
Wait for Q4 Earnings Before Making Any Move on Adamis Pharmaceuticals Stock
09:54am, Tuesday, 30'th Mar 2021
Adamis Pharmaceuticals shares were up in January on the news of its Covid-19 treatment trial, but ADMP stock has been sliding since. The post Wait for Q4 Earnings Before Making Any Move on Adamis Phar
Will Adamis Pharmaceuticals (ADMP) Report Negative Q4 Earnings? What You Should Know
01:37pm, Monday, 22'nd Mar 2021
Adamis (ADMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
09:00am, Monday, 15'th Mar 2021
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) ("Company") announced today that in studies conducted at Galveston National Laboratory (GNL), Universit
Adamis Pharmaceuticals Cleared to Proceed with Human Studies of Tempol for the Treatment of COVID-19
09:00am, Monday, 22'nd Feb 2021
SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) ("Company") announced today that the U.S. Food and Drug Administration (“FDA”) has completed the s
Adamis Pharmaceuticals Strengthens Patent Portfolio for Its Naloxone Product Candidate
09:00am, Wednesday, 17'th Feb 2021
SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) ("Company") today announced that it recently received a notice that one of its patent applications relat
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
09:00am, Friday, 29'th Jan 2021
SAN DIEGO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various the
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
04:01pm, Thursday, 28'th Jan 2021
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various the
Adamis Pharmaceuticals: Locking In Profits While Riding On The Back Of A Phoenix
12:30pm, Sunday, 24'th Jan 2021
Adamis Pharmaceuticals finished 2020 with some Malheur with the company receiving its second CRL for ZIMHI. However, the company is a making a strong comeback thus far in 2021. Adamis plans to appeal
Why Fluidigm, Seelos Therapeutics And More Are Moving Today
11:27am, Friday, 22'nd Jan 2021
Fluidigm (NASDAQ: FLDM) shares are trading higher Friday after the company announced it received the CE-IVD mark for its Advanta Dx SARS-CoV-2 RT-PCR Assay. Fluidigm manufactures life science tools fo
ADMP Stock: 4 Things to Know About Adamis Pharma Today as Shares Rocket Again
09:59am, Friday, 22'nd Jan 2021
Adamis Pharma (ADMP) stock is taking off on Friday after a week of positive news for the company, including a deal with Walgreens. The post ADMP Stock: 4 Things to Know About Adamis Pharma Today as Sh
ADMP Stock Price Increases Over 60% Pre-Market Today: Why It Happened
08:14am, Friday, 22'nd Jan 2021
The stock price of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) has increased over 60% pre-market today. This is why it happened.
SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
04:05pm, Thursday, 21'st Jan 2021
SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its SYMJEPI® (epinephrine) Injection products are now available to members of the W
Adamis (ADMP) Submits Tempol IND for COVID-19, Shares Soar
02:18pm, Thursday, 21'st Jan 2021
Adamis (ADMP) submits an investigational new drug (IND) to the FDA for the investigational use of Tempol for the treatment of COVID-19.
ADMP Stock Alert: The Covid-19 Treatment News That Has Adamis Pharma Shares Soaring Today
11:20am, Wednesday, 20'th Jan 2021
Adamis Pharma (ADMP) stock is taking off on Wednesday following news of its possible treatment for the novel coronavirus. The post ADMP Stock Alert: The Covid-19 Treatment News That Has Adamis Pharma
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
09:00am, Wednesday, 20'th Jan 2021
SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the submission of an Investigational New Drug (IND) to FDA for the investi
Sign In
Buy ADMP